- News Releases
MARLBOROUGH, Mass. and ROCHESTER, Minn. – Boston Scientific Corporation (NYSE: BSX) and Mayo Clinic today announced a continuing collaboration where the two organizations share intellectual property and stimulate the rapid development of medical devices to address unmet clinical needs.
Small and nimble teams of Boston Scientific engineers and Mayo Clinic physicians have been working together to develop new medical technologies in areas that include interventional cardiology, heart rhythm management, endoscopy, neuromodulation, urology and pelvic health. The collaboration enables both parties to contribute ideas and intellectual property to solve pressing medical problems and builds upon the strengths of both parties. Mayo Clinic, which cared for 1.3 million patients in 2015, offers cutting-edge medical and surgical expertise in all disciplines, and has a long history of innovative clinical research and technology development.
“Open approaches to innovation, such as our collaboration with Mayo Clinic, can more quickly put better tools and devices in the hands of physicians to improve the health and well-being of patients,” says Michael F. Mahoney, president and CEO, Boston Scientific. “Our continued investment in this collaboration is an example of our commitment to further investing in jobs and innovation as a result of the recent suspension of the Medical Device Tax.”
Several programs are underway, including two Mayo Clinic studies evaluating:
“We are grateful for the opportunity to collaborate with Boston Scientific,” says John Noseworthy, M.D., president and CEO, Mayo Clinic. “Working together can allow us to swiftly bring our discovery and innovation to the direct benefit of patients.”
Mayo Clinic: Duska Anastasijevic, Mayo Clinic Public Affairs, 507-284-5005, email: email@example.com
Boston Scientific: Tom Keppeler, Media Relations, 508-683-6585, thomas. keppeler@bsci. com
The collaboration is being managed through Mayo Clinic Ventures, which serves Mayo Clinic by finding partners that can bring Mayo’s inventions to the marketplace to improve medicine everywhere. Mayo Clinic Ventures’ mission is straightforward: Commercialize Mayo Clinic technologies for the benefit of patients worldwide while generating revenue to support clinical practice, research and education at Mayo Clinic.
Mayo Clinic has a financial interest in the technology referenced in this news release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit http://www.bostonscientific.com, and connect on Twitter and Facebook.
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to medical research and education, and providing expert, whole-person care to everyone who needs healing. For more information, visit http://www.mayoclinic.org/about-mayo-clinic or https://newsnetwork.mayoclinic.org/.
ROCHESTER, Minn. — Patients who have multiple tumors in one breast may be able to avoid a mastectomy if the tumors can be removed while ...
Consuming too much salt can lead to serious health conditions, including high blood pressure, heart disease and stroke. Many consumers are turning to Himalayan sea salt, ...
JACKSONVILLE, Fla. — Alzheimer's disease affects people of all ethnic groups. Armed with $41 million in new federal funding, Mayo Clinic researchers and colleagues from ...